The chemical class of GAS8 inhibitors encompasses a range of compounds designed to modulate the activity of Growth Arrest-Specific 8 (GAS8), a protein that is integral in cellular processes such as cytoskeletal dynamics and cell growth regulation. These inhibitors are characterized by their ability to interfere with the functions of GAS8, primarily by targeting the pathways and cellular processes in which it is involved. Given GAS8's role in interacting with microtubules and its involvement in the stabilization of the cytoskeletal structure, the inhibitors focus on altering the dynamics of microtubules and actin filaments to regulate the protein's activity. This can be achieved through different mechanisms, including the modulation of microtubule stability or the disruption of microtubule-dependent signaling cascades that GAS8 is a part of.
The inhibition strategies for GAS8 are diverse and are chosen based on the multifaceted nature of its functions. Some inhibitors might work by directly affecting the interaction between GAS8 and microtubules. By doing so, these inhibitors can prevent GAS8 from executing its role in organizing and stabilizing the cytoskeleton, thus impeding its activation and subsequent downstream effects. This type of direct inhibition is crucial for understanding the specific interactions and functions of GAS8 in cytoskeletal dynamics. Other inhibitors operate indirectly, targeting the signaling pathways related to GAS8. For instance, by modulating the assembly or disassembly of actin filaments, these inhibitors can alter the overall dynamics of the cytoskeleton, thereby indirectly influencing the functional outcomes of GAS8's activity. Additionally, compounds that affect the proteins and enzymes interacting with GAS8 or involved in its signaling pathways can also serve as effective inhibitors. This approach is particularly valuable when exploring the broader impact of GAS8 on cellular activities and cytoskeletal organization. The development and study of GAS8 inhibitors are pivotal in advancing our understanding of the protein's role in cytoskeletal dynamics and cell growth regulation. By selectively modulating the activity of GAS8, these inhibitors provide significant insights into the complex interplay between GAS8 and the cytoskeleton, as well as the physiological roles of GAS8. The specificity of these inhibitors is key, not only for delineating the precise functions of GAS8 but also for unraveling the interconnected networks of cellular signaling and structural organization. As research in this area progresses, GAS8 inhibitors continue to be an important focus, enabling a deeper exploration of cellular dynamics and contributing to our broader understanding of the role of cytoskeletal elements in cellular physiology and growth regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Could possibly inhibit GAS8 by destabilizing microtubules and affecting GAS8's interaction with microtubules. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Could possibly inhibit GAS8 by binding tubulin and inhibiting microtubule polymerization, affecting cytoskeletal organization. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Could possibly inhibit GAS8 if it is involved in actin dynamics, by inhibiting actin polymerization. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Could possibly influence signaling pathways involving GAS8 by activating adenylate cyclase. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Could possibly affect GAS8 by inhibiting ROCK, impacting actin cytoskeleton dynamics. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Could possibly affect GAS8 by inhibiting myosin light chain kinase, impacting cytoskeletal dynamics. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Could possibly inhibit GAS8 by inhibiting myosin II, affecting cellular processes involving the cytoskeleton. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Could possibly inhibit GAS8 by disrupting actin filaments, if GAS8 is involved in actin dynamics. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
Could possibly inhibit GAS8 by inhibiting the Arp2/3 complex, affecting actin polymerization. | ||||||